Home

abrdn Life Sciences Investors (HQL)

14.21
+0.05 (0.35%)

Abrdn Life Sciences Investors is a publicly traded investment company that focuses on identifying and investing in innovative companies within the life sciences sector

The firm aims to generate long-term capital appreciation by actively managing a diversified portfolio of life sciences firms, including those involved in pharmaceuticals, biotechnology, medical devices, and related fields. Through its strategic investments, the company seeks to capitalize on advances in healthcare technology and drive positive outcomes in patient care while delivering value to its shareholders.

SummaryNewsPress ReleasesChartHistoricalFAQ
Around $1.5M Bet On Abrdn Life Sciences Investors? Check Out These 3 Stocks Insiders Are Buyingbenzinga.com
Via Benzinga · April 30, 2024
Wednesday Is Your Last Chance To Buy Tekla Life Sciences Invts Before The Dividend Payoutbenzinga.com
Via Benzinga · August 21, 2023
Tekla Life Sciences: Dividend Insightsbenzinga.com
Tuesday marks the last chance for investors to receive the next dividend payout from Tekla Life Sciences (NYSEHQL).
Via Benzinga · November 18, 2022
Tekla Life Sciences: Dividend Insightsbenzinga.com
Wednesday marks the last chance for investors to receive the next dividend payout from Tekla Life Sciences (NYSEHQL).
Via Benzinga · August 22, 2022
Tekla Life Sciences's Ex-Dividend Date Is Thursday, Here's What You Need To Knowbenzinga.com
Wednesday marks the last chance for investors to receive the next dividend payout from Tekla Life Sciences (NYSEHQL).
Via Benzinga · May 23, 2022